March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in your inbox.
Obtener información acerca de las razones las mujeres mayores se pasan por alto a pesar de estar en riesgo de contraer el VIH, cómo el conocimiento es poder, y la importancia de hacerse la prueba.
Learn what opportunistic infections (OIs) are, including specifics about nine OIs, how people get them, and how to treat and prevent them.